China has approved its first vaccine for use against the coronavirus. The vaccine, developed by Chinese vaccine company CanSino Biologics, has been officially patented. It is also in ‘Phase III’ trials in Saudi Arabia, opening the way to rapid mass production.
However, the UK’s media have been remarkably silent on the news.
Presumably this is because the Tory government has been boasting about the UK’s ‘world-beating’ performance in anti-COVID treatments – so the revelation that once again ‘the world’, as with this country’s supposed pandemic preparedness and its test-and-trace system, isn’t actually being beaten will be more than a little inconvenient.
By contrast, the news is all over the media in Italy and other countries that have suffered badly from the virus and has been reported by international news service Reuters.
The company has issued a statement saying that the patent approval
is further confirmation of the efficacy and safety”
of the virus.
The potentially imminent availability of a ready coronavirus vaccine is of considerable interest to the world’s population, especially when a UK version is still not expected to be available until early next year at best, but the UK media seem to have ‘missed’ it.
The SKWAWKBOX is provided free of charge but depends on the support of its readers to be viable. If you can afford to, please click here to arrange a one-off or modest monthly donation via PayPal or here to set up a monthly donation via GoCardless (SKWAWKBOX will contact you to confirm the GoCardless amount). Thanks for your solidarity so SKWAWKBOX can keep bringing you information the Establishment would prefer you not to know about.
If you wish to republish this post for non-commercial use, you are welcome to do so – see here for more.